Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment his Department has made of the effect of the UK leaving the EU on the price of medication sold online by third parties.

The Government is assessing the potential implications of the United Kingdom’s withdrawal from the European Union across the medicines supply chain. While we cannot pre-judge the outcome of the negotiations, our aim is to ensure that patients in the UK and across the EU will continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data.